SCHEMBL4581571

SCHEMBL4581571

COc1cc(Nc2ccc(C#N)c(NCCO)c2)c(Cl)c(OC)c1OC

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
S1PR3 Q99500 1/20 0.37
BCL6 P41182 1/20 0.37
DYRK1A Q13627 1/20 0.37
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35
IDH1 O75874 1/20 0.35
PGR P06401 1/20 0.35
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
STK4 Q13043 1/20 0.35
SRC P12931 3/20 0.34
IGF1R P08069 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14252659 0.88 SRC (0.46) ALDH1A1HPGDGAAMAPTS1PR3
SCHEMBL4581255 0.83 DYRK1A (0.41) ALDH1A1HPGDGAAMAPTDYRK1A
SCHEMBL4581973 0.83 DYRK1A (0.41) ALDH1A1HPGDGAAMAPTDYRK1A
SCHEMBL4581092 0.80 MAPK9 (0.43) ALDH1A1HPGDBCL6KMT2A
SCHEMBL5162466 0.68 POLB (0.44) ALDH1A1GAABCL6KMT2APOLB
SCHEMBL18893406 0.66 PTGS2 (0.40) ALDH1A1MAPTKMT2APOLB
SCHEMBL4581874 0.65 SRC (0.42) ALDH1A1DYRK1AEGFRERBB2SRC
SCHEMBL12844701 0.64 PGK1 (0.41) ALDH1A1DYRK1A
SCHEMBL7528112 0.64 KDM4E (0.58) ALDH1A1HPGDGAAKMT2APOLB
SCHEMBL9525237 0.64 CYP3A4 (0.47) ALDH1A1MAPTKMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US claimed
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US disclosed
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US disclosed
WO-2008024963-A1 BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES SERENEX, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives RB1, MKI67, CCNB1 ALDH1A1 767/4885HPGD 660/4885GAA 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.